AngioDynamics (ANGO): Shares define bullish 'flag' pattern

Filed under: Earnings reports, Johnson and Johnson (JNJ), Boston Scientific (BSX), Technical Analysis, Stocks to Buy

AngioDynamics (NASDAQ: ANGO) provides medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. The firm's oncology product line includes image-guided radiofrequency ablation devices, used to kill cancer cells by heating and destroying them. The peripheral vascular line includes a variety of instruments to clear and drain non-cardiac arteries. The company's products are sold in more than thirty countries. Competitors include Johnson & Johnson (NYSE: JNJ) and Boston Scientific (NYSE: BSX).

The firm pleased investors late last month, when it reported fiscal Q4 EPS of 41 cents and revenues of $46.8 million. Analysts had been looking for 17 cents and $45.6 million. Management also guided FY09 EPS to 68 cents (64 cent consensus) and FY09 revenues to $205-$210 million ($201.32M consensus).

Continue reading AngioDynamics (ANGO): Shares define bullish 'flag' pattern

Permalink | Email this | Comments

<map name="google_ad_map_145-1283145"><area href="http://imageads.googleadservices.com/pagead/imgclick/145-1283145?pos=0" shape="rect" coords="1,2,367,28" /><area href="http://services.google.com/feedback/abg" shape="rect" coords="384,10,453,23" /></map>